Versant Venture Capital VI, L.P. Insider Trading $ALGS Aligos Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Versant Venture Capital VI, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Versant Venture Capital VI, L.P.. Versant Venture Capital VI, L.P. is 10% Owner in Black Diamond Therapeutics, Inc. ($BDTX) and 10% Owner in Oyster Point Pharma, Inc. ($OYST) and 10% Owner in Akero Therapeutics, Inc. ($AKRO) and 10% Owner in Aligos Therapeutics, Inc. ($ALGS) and 10% Owner in Pandion Therapeutics, Inc. ($PAND).
Versant Venture Capital VI, L.P. in Aligos Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Versant Venture Capital VI, L.P.: 10% Owner
Holdings: 2,145,991 shares
Latest Transaction: Oct 20 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Versant Venture Capital VI, L.P. in Aligos Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKRO, ALGS, BDTX, OYST, PAND
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 198,485 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 85,065 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 463,959 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 198,839 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 2,145,991 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | P | 15.00 | 200,000 | 3,000,000 | 862,444 | 662.4 K to 862.4 K (+30.19 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 198,485 | 0 | 662,444 | 464 K to 662.4 K (+42.78 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 463,959 | 0 | 463,959 | 0 to 464 K |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 85,065 | 0 | 2,429,895 | 2.3 M to 2.4 M (+3.63 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 198,839 | 0 | 2,344,830 | 2.1 M to 2.3 M (+9.27 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 2,145,991 | 0 | 2,145,991 | 0 to 2.1 M |
Page: 1